About this trial
Prolonged sedentary conditions contribute to declining health across human populations and cause significant secondary health consequences for many patients whose illnesses or injuries prevent them from exercising. The investigators have demonstrated that in a small animal fruit fly model, genetic stimulation of neurons that promote adrenergic signaling is sufficient to mimic the benefits of exercise training even in sedentary animals. The investigator's pilot work in humans has confirmed that humans respond to Virtual Reality (VR) stimuli that mimic exercise by increasing heart rate and altering heart rate variability in a way consistent with increased adrenergic activity.
In this study, the investigators will directly test for the first time whether repeated, controlled exposure to VR stimuli that induce adrenergic activity in sedentary humans can produce adaptive changes to protein expression and endurance performance like those produced by actual exercise in pre-diabetic participants with/without hypertension.
Eligibility criteria
Qualifiers
Equal numbers male and female (32 each)
Blood glucose HbA1C: 5.7-6.4% or 100-125 mg/dL
BP: systolic<120 and diastolic<80 mmHg, systolic 120-129 mmHg and diastolic <80 mmHg, or systolic >130 mmHg and diastolic >80 mmHg
Disqualifiers
BMI>35kg/m2
Currently involved in an exercise program or similar activity
Taking medications that could affect results, including beta-blockers or SSRIs
Demonstrate any form of discomfort with the VR experience through self-reported feelings of anxiety or nausea
Trial design
Treatments tested in this trial
- 20 minutes cycling exercise
- Virtual Reality
Treatment groups
Sponsors and collaborators
Wayne State University
Lead sponsor
National Institute on Aging (NIA)
Collaborator